AVISE MTX

Methotrexate Polyglutamates Test

Image


AVISE MTX


Methotrexate Polyglutamates Test



AVISE MTX provides accurate measurement of the active methotrexate (MTX) metabolites, methotrexate polyglutamates (MTXPGs), to help physicians appropriately assess their patients' exposure to methotrexate.

AVISE MTX helps assess variability in methotrexate pharmacokinetics.

AVISE Methotrexate Test
Image
Image
Image

Clinical Utility

The AVISE MTX test is intended for use in patients on methotrexate treatment, after steady state (approx. 90 days), to help with therapeutic decision making including: 


  • Drug delivery route, i.e. oral vs. subcutaneous MTX therapy
  • Treatment changes

Image

2. Dervieux T, et al. Ann Rheum Dis 2005. 

AVISE MTX Test Report

The AVISE MTX test is available via venous draw and through AVISE Touch, a low volume capillary draw device.

You deserve quality test results you can trust. Order your AVISE Testing Starter Kit today!


To order your test kits please fill out the information below.